메뉴 건너뛰기




Volumn 25, Issue SUPPL. 1, 2009, Pages

Carnitine and type 2 diabetes

Author keywords

Acetyl CoA; Carnitine; Diabetes; Insulin resistance

Indexed keywords

ACETYLCARNITINE; CARNITINE; CARNITINE PALMITOYLTRANSFERASE; INSULIN;

EID: 73349102478     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.987     Document Type: Conference Paper
Times cited : (39)

References (30)
  • 1
    • 8844255630 scopus 로고    scopus 로고
    • Free fatty acids in obesity and type 2 diabetes: Defining their role in the development of insulin resistance and beta-cell dysfunction
    • Boden G, Shulman GI. Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction. Eur J Clin Invest 2002; 32(Suppl 3): 14-23.
    • (2002) Eur J Clin Invest , vol.32 , Issue.SUPPL. 3 , pp. 14-23
    • Boden, G.1    Shulman, G.I.2
  • 2
    • 0036092239 scopus 로고    scopus 로고
    • Banting lecture 2001: Dysregulation of fatty acid metabolism in the etiology of type 2 diabetes
    • McGarry JD. Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes 2002; 51: 7-18.
    • (2002) Diabetes , vol.51 , pp. 7-18
    • McGarry, J.D.1
  • 3
    • 0033927667 scopus 로고    scopus 로고
    • Cellular mechanisms of insulin resistance
    • Shulman GI. Cellular mechanisms of insulin resistance. J Clin Invest 2000; 106: 171-176.
    • (2000) J Clin Invest , vol.106 , pp. 171-176
    • Shulman, G.I.1
  • 4
    • 0036182137 scopus 로고    scopus 로고
    • Lipotoxic diseases
    • Unger RH. Lipotoxic diseases. Annu Rev Med 2002; 53: 319-336.
    • (2002) Annu Rev Med , vol.53 , pp. 319-336
    • Unger, R.H.1
  • 5
    • 0034076660 scopus 로고    scopus 로고
    • Fuel selection in human skeletal muscle in insulin resistance: A reexamination
    • Kelley DE, Mandarino LJ. Fuel selection in human skeletal muscle in insulin resistance: a reexamination. Diabetes 2000; 49: 677-683.
    • (2000) Diabetes , vol.49 , pp. 677-683
    • Kelley, D.E.1    Mandarino, L.J.2
  • 6
    • 0030669094 scopus 로고    scopus 로고
    • Protein kinase C modulation of insulin receptor substrate-1 tyrosine phosphorylation requires serine 612
    • De Fea K, Roth RA. Protein kinase C modulation of insulin receptor substrate-1 tyrosine phosphorylation requires serine 612. Biochemistry 1997; 36: 12939-12947.
    • (1997) Biochemistry , vol.36 , pp. 12939-12947
    • De Fea, K.1    Roth, R.A.2
  • 7
    • 0035793592 scopus 로고    scopus 로고
    • Protein kinase C-zeta phosphorylates insulin receptor substrate-1 and impairs its ability to activate phosphatidylinositol 3-kinase in response to insulin
    • Ravichandran LV, Esposito DL, Chen J, Quon MJ. Protein kinase C-zeta phosphorylates insulin receptor substrate-1 and impairs its ability to activate phosphatidylinositol 3-kinase in response to insulin. J Biol Chem 2001; 276: 3543-3549.
    • (2001) J Biol Chem , vol.276 , pp. 3543-3549
    • Ravichandran, L.V.1    Esposito, D.L.2    Chen, J.3    Quon, M.J.4
  • 8
    • 0038532298 scopus 로고    scopus 로고
    • A role for ceramide, but not diacylglycerol, in the antagonism of insulin signal transduction by saturated fatty acids
    • Chavez JA, Knotts TA, Wang LP, Li G, Dobrowsky RT. A role for ceramide, but not diacylglycerol, in the antagonism of insulin signal transduction by saturated fatty acids. J Biol Chem 2003; 278: 10297-10303.
    • (2003) J Biol Chem , vol.278 , pp. 10297-10303
    • Chavez, J.A.1    Knotts, T.A.2    Wang, L.P.3    Li, G.4    Dobrowsky, R.T.5
  • 9
    • 0029853098 scopus 로고    scopus 로고
    • Lipid mediators of insulin resistance: Ceramide signalling down-regulates GLUT4 gene transcription in 3T3-L1 adipocytes
    • Long SD, Pekala PH. Lipid mediators of insulin resistance: ceramide signalling down-regulates GLUT4 gene transcription in 3T3-L1 adipocytes. Biochem J 1996; 319: 179-184.
    • (1996) Biochem J , vol.319 , pp. 179-184
    • Long, S.D.1    Pekala, P.H.2
  • 10
    • 33847332202 scopus 로고    scopus 로고
    • Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance
    • Holland WL, Brozinick JJ, Wang LP, Hawkins ED, Sargent KM, et al. Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance. Cell Metab 2007; 5: 167-179.
    • (2007) Cell Metab , vol.5 , pp. 167-179
    • Holland, W.L.1    Brozinick, J.J.2    Wang, L.P.3    Hawkins, E.D.4    Sargent, K.M.5
  • 11
    • 37449020075 scopus 로고    scopus 로고
    • Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance
    • Koves TR, Ussher JR, Noland RC, Slentz D, Mosedale M, Ilkayeva O, et al. Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. Cell Metab 2008; 7: 45-56.
    • (2008) Cell Metab , vol.7 , pp. 45-56
    • Koves, T.R.1    Ussher, J.R.2    Noland, R.C.3    Slentz, D.4    Mosedale, M.5    Ilkayeva, O.6
  • 12
    • 36148937475 scopus 로고    scopus 로고
    • Skeletal muscle adaptation to fatty acid depends on coordinated actions of the PPARs and PGC1 alpha: Implications for metabolic disease
    • Muoio DM, Koves TR. Skeletal muscle adaptation to fatty acid depends on coordinated actions of the PPARs and PGC1 alpha: implications for metabolic disease. Appl Physiol Nutr Metab 2007; 32: 874-883.
    • (2007) Appl Physiol Nutr Metab , vol.32 , pp. 874-883
    • Muoio, D.M.1    Koves, T.R.2
  • 13
    • 42449152466 scopus 로고    scopus 로고
    • Muoio DM, Koves TR. Lipid-induced metabolic dysfunction in skeletal muscle. Novartis Found Symp 2007; 286: 24-38; discussion 38-46, 162-3, 196-203.
    • Muoio DM, Koves TR. Lipid-induced metabolic dysfunction in skeletal muscle. Novartis Found Symp 2007; 286: 24-38; discussion 38-46, 162-3, 196-203.
  • 14
    • 0025748024 scopus 로고
    • Carnitine improves peripheral glucose disposal in non-insulin-dependent diabetic patients
    • Capaldo B, Napoli R, Di Bonito P, Albano G,Sacca L. Carnitine improves peripheral glucose disposal in non-insulin-dependent diabetic patients. Diabetes Res Clin Pract 1991; 14: 191-195.
    • (1991) Diabetes Res Clin Pract , vol.14 , pp. 191-195
    • Capaldo, B.1    Napoli, R.2    Di Bonito, P.3    Albano, G.4    Sacca, L.5
  • 19
    • 34249724327 scopus 로고    scopus 로고
    • New insights concerning the role of carnitine in the regulation of fuel metabolism in skeletal muscle
    • Stephens FB, Constantin-Teodosiu D, Greenhaff PL. New insights concerning the role of carnitine in the regulation of fuel metabolism in skeletal muscle. J Physiol 2007; 581: 431-444.
    • (2007) J Physiol , vol.581 , pp. 431-444
    • Stephens, F.B.1    Constantin-Teodosiu, D.2    Greenhaff, P.L.3
  • 21
    • 3042551249 scopus 로고    scopus 로고
    • Increased beta-oxidation in muscle cells enhances insulin-stimulated glucose metabolism and protects against fatty acid-induced insulin resistance despite intramyocellular lipid accumulation
    • Perdomo G, Commerford SR, Richard AM, Adams SH, Corkey BE, O'Doherty RM, et al. Increased beta-oxidation in muscle cells enhances insulin-stimulated glucose metabolism and protects against fatty acid-induced insulin resistance despite intramyocellular lipid accumulation. J Biol Chem 2004; 279: 27177-27186.
    • (2004) J Biol Chem , vol.279 , pp. 27177-27186
    • Perdomo, G.1    Commerford, S.R.2    Richard, A.M.3    Adams, S.H.4    Corkey, B.E.5    O'Doherty, R.M.6
  • 23
    • 49549121822 scopus 로고    scopus 로고
    • Effect of oral L-carnitine administration on insulin sensitivity and lipid profile in type 2 diabetes mellitus patients
    • Gonzalez-Ortiz M, Hernandez-Gonzalez SO, Hernandez-Salazar E, Martinez-Abundis E. Effect of oral L-carnitine administration on insulin sensitivity and lipid profile in type 2 diabetes mellitus patients. Ann Nutr Metab 2008; 52: 335-358.
    • (2008) Ann Nutr Metab , vol.52 , pp. 335-358
    • Gonzalez-Ortiz, M.1    Hernandez-Gonzalez, S.O.2    Hernandez-Salazar, E.3    Martinez-Abundis, E.4
  • 24
    • 24044475940 scopus 로고    scopus 로고
    • The effects of oral L-carnitine treatment on blood lipid metabolism and the body fat content in the diabetic patient
    • Liang Y. The effects of oral L-carnitine treatment on blood lipid metabolism and the body fat content in the diabetic patient. Asia Pac J Clin Nutr 1998; 7: 192-195.
    • (1998) Asia Pac J Clin Nutr , vol.7 , pp. 192-195
    • Liang, Y.1
  • 25
    • 0037945488 scopus 로고    scopus 로고
    • The effect of L-carnitine on plasma lipoprotein(a) levels in hypercholesterolemic patients with type 2 diabetes mellitus
    • Derosa G, Cicero AF, Gaddi A , Mugellini A, Ciccarelli L, Fogari R, et al. The effect of L-carnitine on plasma lipoprotein(a) levels in hypercholesterolemic patients with type 2 diabetes mellitus. Clin Ther 2003; 25: 1429-1439.
    • (2003) Clin Ther , vol.25 , pp. 1429-1439
    • Derosa, G.1    Cicero, A.F.2    Gaddi, A.3    Mugellini, A.4    Ciccarelli, L.5    Fogari, R.6
  • 26
    • 17244363019 scopus 로고    scopus 로고
    • Effect of L-carnitine on plasma glycemic and lipidemic profile in patients with type II diabetes mellitus
    • Rahbar AR, Shakerhosseini R, Saadat N, Taleban F, Pordal A, Gollestan B, et al. Effect of L-carnitine on plasma glycemic and lipidemic profile in patients with type II diabetes mellitus. Eur J Clin Nutr 2005; 59: 592-596.
    • (2005) Eur J Clin Nutr , vol.59 , pp. 592-596
    • Rahbar, A.R.1    Shakerhosseini, R.2    Saadat, N.3    Taleban, F.4    Pordal, A.5    Gollestan, B.6
  • 28
    • 0023033189 scopus 로고
    • Dose-dependent lipotropic effect of carnitine in chronic alcoholic rats
    • Rhew TH, Sachan DS. Dose-dependent lipotropic effect of carnitine in chronic alcoholic rats. J Nutr 1986; 116: 2263-2269.
    • (1986) J Nutr , vol.116 , pp. 2263-2269
    • Rhew, T.H.1    Sachan, D.S.2
  • 29
    • 0026741982 scopus 로고
    • Effects of L-carnitine on carbon tetrachloride-induced changes in serum and liver lipids and acylcarnitines
    • Sachan DS, Dodson WL. Effects of L-carnitine on carbon tetrachloride-induced changes in serum and liver lipids and acylcarnitines. J Environ Pathol Toxicol Oncol 1992; 11: 125-129.
    • (1992) J Environ Pathol Toxicol Oncol , vol.11 , pp. 125-129
    • Sachan, D.S.1    Dodson, W.L.2
  • 30
    • 53749084068 scopus 로고    scopus 로고
    • Carnitine in metabolic disease: Potential for pharmacological intervention
    • Arduini A, Bonomini M, Savica V, Amato A, Zammit V. Carnitine in metabolic disease: potential for pharmacological intervention. Pharmacol Ther 2008; 120: 149-56.
    • (2008) Pharmacol Ther , vol.120 , pp. 149-156
    • Arduini, A.1    Bonomini, M.2    Savica, V.3    Amato, A.4    Zammit, V.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.